BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26213846)

  • 1. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway.
    Lei JJ; Peng RJ; Kuang BH; Yuan ZY; Qin T; Liu WS; Guo YM; Han HQ; Lian YF; Deng CC; Zhang HJ; Chen LZ; Feng QS; Xu M; Feng L; Bei JX; Zeng YX
    Oncotarget; 2015 Sep; 6(28):25701-14. PubMed ID: 26213846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOP14 regulates the growth, migration, and invasion of colorectal cancer cells by modulating the NRIP1/GSK-3β/β-catenin signaling pathway.
    Zhu X; Jia W; Yan Y; Huang Y; Wang B
    Eur J Histochem; 2021 Jul; 65(3):. PubMed ID: 34218653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway.
    Li J; Fang R; Wang J; Deng L
    Braz J Med Biol Res; 2018 Nov; 52(1):e7952. PubMed ID: 30484495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation.
    Li J; Fang R; Wu J; Si Y; Bai J; Wang Q
    Bioengineered; 2022 Mar; 13(3):7648-7658. PubMed ID: 35282769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of XB130 in human ductal breast cancer.
    Li J; Sun W; Wei H; Wang X; Li H; Yi Z
    Int J Clin Exp Pathol; 2015; 8(5):5300-8. PubMed ID: 26191231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
    Cai J; Guan H; Fang L; Yang Y; Zhu X; Yuan J; Wu J; Li M
    J Clin Invest; 2013 Feb; 123(2):566-79. PubMed ID: 23321667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.
    Li X; Liang W; Liu J; Lin C; Wu S; Song L; Yuan Z
    Breast Cancer Res; 2014 Oct; 16(5):465. PubMed ID: 25341494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
    Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer.
    Yin X; Xiang T; Li L; Su X; Shu X; Luo X; Huang J; Yuan Y; Peng W; Oberst M; Kelly K; Ren G; Tao Q
    Breast Cancer Res; 2013 Mar; 15(2):R23. PubMed ID: 23497530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo.
    Aziz MH; Chen X; Zhang Q; DeFrain C; Osland J; Luo Y; Shi X; Yuan R
    Oncotarget; 2015 Nov; 6(37):39714-24. PubMed ID: 26492163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma.
    Hu A; Hong F; Li D; Xie Q; Chen K; Zhu L; He H
    Cancer Gene Ther; 2022 Feb; 29(2):215-224. PubMed ID: 33828234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer.
    Yu Y; Yin W; Yu ZH; Zhou YJ; Chi JR; Ge J; Cao XC
    J Exp Clin Cancer Res; 2019 Jan; 38(1):22. PubMed ID: 30658681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
    Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
    Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.